| Year |
Citation |
Score |
| 2023 |
Yang X, Tripathi R, Wang M, Lu W, Anifowose A, Tan C, Wang B. Toward "CO in a Pill": Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via Gastrointestinal CO Release. Molecular Pharmaceutics. PMID 36802675 DOI: 10.1021/acs.molpharmaceut.2c01104 |
0.7 |
|
| 2022 |
Yang X, Yuan Z, Lu W, Yang C, Wang M, Tripathi R, Fultz Z, Tan C, Wang B. De Novo Construction of Fluorophores via CO Insertion-Initiated Lactamization: A Chemical Strategy toward Highly Sensitive and Highly Selective Turn-On Fluorescent Probes for Carbon Monoxide. Journal of the American Chemical Society. PMID 36548940 DOI: 10.1021/jacs.2c07504 |
0.587 |
|
| 2022 |
Tripathi R, Anifowose A, Lu W, Yang X, Wang B. Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core. Journal of Enzyme Inhibition and Medicinal Chemistry. 37: 2370-2381. PMID 36043494 DOI: 10.1080/14756366.2022.2116699 |
0.697 |
|
| 2022 |
Lu W, Yang X, Wang B. Carbon monoxide signaling and soluble guanylyl cyclase: Facts, myths, and intriguing possibilities. Biochemical Pharmacology. 200: 115041. PMID 35447132 DOI: 10.1016/j.bcp.2022.115041 |
0.615 |
|
| 2022 |
Yang X, Lu W, Wang M, De La Cruz LK, Tan C, Wang B. Activated charcoal dispersion of carbon monoxide prodrugs for oral delivery of CO in a pill. International Journal of Pharmaceutics. 618: 121650. PMID 35276229 DOI: 10.1016/j.ijpharm.2022.121650 |
0.627 |
|
| 2021 |
Yang X, Lu W, Wang M, Tan C, Wang B. "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 34481027 DOI: 10.1016/j.jconrel.2021.08.059 |
0.639 |
|
| 2021 |
De La Cruz LK, Yang X, Menshikh A, Brewer M, Lu W, Wang M, Wang S, Ji X, Cachuela A, Yang H, Gallo D, Tan C, Otterbein L, de Caestecker M, Wang B. Adapting decarbonylation chemistry for the development of prodrugs capable of delivery of carbon monoxide utilizing sweeteners as carrier molecules. Chemical Science. 12: 10649-10654. PMID 34447558 DOI: 10.1039/d1sc02711e |
0.746 |
|
| 2021 |
Yang X, Lu W, Hopper CP, Ke B, Wang B. Nature's marvels endowed in gaseous molecules I: Carbon monoxide and its physiological and therapeutic roles. Acta Pharmaceutica Sinica. B. 11: 1434-1445. PMID 34221861 DOI: 10.1016/j.apsb.2020.10.010 |
0.701 |
|
| 2020 |
Anifowose A, Agbowuro AA, Tripathi R, Lu W, Tan C, Yang X, Wang B. Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs. Medicinal Chemistry Research : An International Journal For Rapid Communications On Design and Mechanisms of Action of Biologically Active Agents. 29: 1199-1210. PMID 32719577 DOI: 10.1007/S00044-020-02563-Y |
0.697 |
|
| 2020 |
Yang XX, Ke BW, Lu W, Wang BH. CO as a therapeutic agent: discovery and delivery forms. Chinese Journal of Natural Medicines. 18: 284-295. PMID 32402406 DOI: 10.1016/S1875-5364(20)30036-4 |
0.714 |
|
| 2017 |
Zhang J, Shi Y, Zheng Y, Pan C, Yang X, Dou T, Wang B, Lu W. Homing in on an intracellular target for delivery of loaded nanoparticles functionalized with a histone deacetylase inhibitor. Oncotarget. 8: 68242-68251. PMID 28978112 DOI: 10.18632/Oncotarget.20021 |
0.675 |
|
| 2013 |
Yang X, Lin H, Lu W, Wang D. Compatibility study of Merrifield linker in Fmoc strategy peptide synthesis. Protein and Peptide Letters. 20: 140-5. PMID 22894150 |
0.408 |
|
| Show low-probability matches. |